INTERNATIONAL PATENT: REIGNITE THERAPEUTICS INC. FILES APPLICATION FOR "RECOMBINANT VACCINIA VIRUS AND METHODS OF USE THEREOF"

GENEVA, March 18 -- REIGNITE THERAPEUTICS INC. (6195 CornerstoneCourt E #103San Diego, CA. 92121) filed a patent application (PCT/US2024/045092) for "RECOMBINANT VACCINIA VIRUS AND METHODS OF USE THEREOF" on Sep 04, 2024. With publication no. WO/2025/054144, the details related to the patent application was published on Mar 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MARURI AVIDAL, Liliana (c/o Reignite Therapeutics Inc.626 Bancroft WaySuite ABerkeley, California 94710), KIRN, David H. (c/o Reignite Therapeutics Inc.626 Bancroft WaySuite ABerkeley, California 94710), MITCHELL, Leah A...